Tag: Theravance

Posted on

GlaxoSmithKline, Theravance Combined Drug for COPD Shows Postitive Results – FOXBusiness


Proactive Investors USA & Canada

GlaxoSmithKline, Theravance Combined Drug for COPD Shows Postitive Results
FOXBusiness
… Wednesday that their combined treatment for patients with chronic obstructive pulmonary disorder and asthma posted strong results in a clinical study. …
Glaxo, Theravance report Relovair safety dataBusinessWeek
GSK and Theravance announce combination ICS/LABA Phase II results in the …MarketWatch (press release)
GlaxoSmithKline and Theravance announce positive phase II results for Relovair …Proactive Investors USA & Canada
FierceBiotech –RTT News
all 38 news articles »

View full post on asthma – Google News

Posted on

Glaxo, Theravance report Relovair safety data – BusinessWeek

Glaxo, Theravance report Relovair safety data
BusinessWeek
GlaxoSmithKline PLC and Theravance Inc. said Wednesday their lung disease and asthma drug Relovair met its goals in a mid-stage safety study. …
GSK and Theravance announce combination ICS/LABA Phase II results in the …MarketWatch (press release)
GlaxoSmithKline Reports Positive Results For Phase II Trial Of Relovair In …RTT News
Theravance Announces Results From Phase II Study For Developmental Combination …Stock Markets Review

all 31 news articles »

View full post on asthma – Google News

Posted on

GSK and Theravance announce combination ICS/LABA Phase II results in the … – MarketWatch (press release)

GSK and Theravance announce combination ICS/LABA Phase II results in the …
MarketWatch (press release)
Our ongoing collaboration with GSK includes the Phase III programmes in both COPD and asthma, which are already underway for Relovair and its components. …
Theravance Announces Results From Phase II Study For Developmental Combination …Stock Markets Review

all 10 news articles »

View full post on asthma – Google News